4.7 Article

Epidemiology of Medically Attended Respiratory Syncytial Virus Lower Respiratory Tract Infection in Japanese Children, 2011-2017

Related references

Note: Only part of the references are listed.
Article Medicine, General & Internal

Bivalent Prefusion F Vaccine in Pregnancy to Prevent RSV Illness in Infants

B. Kampmann et al.

Summary: Vaccination of pregnant women with RSVpreF vaccine was effective in reducing severe RSV-associated lower respiratory tract illness in infants. The vaccine showed 81.8% efficacy within 90 days and 69.4% efficacy within 180 days. The vaccine was found to be safe for both mothers and infants.

NEW ENGLAND JOURNAL OF MEDICINE (2023)

Review Immunology

Respiratory Syncytial Virus-Associated Hospitalization Rates among US Infants: A Systematic Review and Meta-Analysis

John M. McLaughlin et al.

Summary: Our systematic literature review and meta-analysis on RSV-associated hospitalization rates among US infants revealed an annual range from 8.4 to 40.8 per 1000, with a pooled rate of 19.4 per 1000. Study type significantly influenced the rates, with active surveillance studies showing lower rates (11.0) compared to studies using administrative claims (21.4) or modeling approaches (23.2).

JOURNAL OF INFECTIOUS DISEASES (2022)

Article Immunology

Respiratory Syncytial Virus-Associated Hospital Admissions and Bed Days in Children <5 Years of Age in 7 European Countries

Xin Wang et al.

Summary: A study has found that respiratory syncytial virus (RSV) is a leading cause of respiratory tract infections in young children. Prevention therapies such as monoclonal antibodies and maternal vaccines can help reduce the number of bed days due to RSV-associated respiratory tract infections in infants. When developing RSV immunization schedules, high-risk birth months should be taken into consideration.

JOURNAL OF INFECTIOUS DISEASES (2022)

Article Medicine, General & Internal

Prefusion F Protein-Based Respiratory Syncytial Virus Immunization in Pregnancy

Eric A. F. Simoes et al.

Summary: This study investigated the efficacy, immunogenicity, and safety of a bivalent RSVpreF vaccine in pregnant women and their infants. The results showed that the vaccine elicited a strong immune response and efficient transplacental transfer, without any evident safety concerns.

NEW ENGLAND JOURNAL OF MEDICINE (2022)

Article Medicine, General & Internal

Nirsevimab for Prevention of RSV in Healthy Late-Preterm and Term Infants

Laura L. Hammitt et al.

Summary: A single injection of nirsevimab administered before the RSV season protected healthy late-preterm and term infants from medically attended RSV-associated lower respiratory tract infection.

NEW ENGLAND JOURNAL OF MEDICINE (2022)

Letter Medicine, General & Internal

Safety of Nirsevimab for RSV in Infants with Heart or Lung Disease or Prematurity

Joseph Domachowske et al.

NEW ENGLAND JOURNAL OF MEDICINE (2022)

Article Immunology

Respiratory Syncytial Virus Is the Leading Cause of United States Infant Hospitalizations, 2009-2019: A Study of the National (Nationwide) Inpatient Sample

Mina Suh et al.

Summary: This study demonstrates that acute bronchiolitis due to RSV is the leading cause of hospitalizations in US infants, especially during the winter months.

JOURNAL OF INFECTIOUS DISEASES (2022)

Review Immunology

A Systematic Literature Review of the Burden of Respiratory Syncytial Virus and Health Care Utilization Among United States Infants Younger Than 1 Year( )

Mina Suh et al.

Summary: A systematic review of studies on respiratory syncytial virus (RSV) and bronchiolitis in US infants revealed substantial variability in the burden and healthcare utilization rates. Nationally representative studies are needed to understand the impact of RSV and healthcare utilization.

JOURNAL OF INFECTIOUS DISEASES (2022)

Article Immunology

Medically Attended Illness due to Respiratory Syncytial Virus Infection Among Infants Born in the United States Between 2016 and 2020

Jason R. Gantenberg et al.

Summary: RSV is a major cause of infant hospitalization in the United States. While preterm infants and those with specific comorbidities are at high risk, 80% of RSV infections occur in term infants without comorbidities. Future prevention efforts should target all infants.

JOURNAL OF INFECTIOUS DISEASES (2022)

Article Health Care Sciences & Services

The Long-Term Healthcare Utilization and Economic Burden of RSV Infection in Children ≤5 Years in Japan: Propensity Score Matched Cohort Study

Viktor Chirikov et al.

Summary: This study aimed to estimate the long-term healthcare utilization and cost burden of RSV infection in Japan. The results showed that RSV infection led to higher healthcare utilization and cost burden among children.

CLINICOECONOMICS AND OUTCOMES RESEARCH (2022)

Article Multidisciplinary Sciences

Shortness of breath in children at the emergency department: Variability in management in Europe

Dorine Borensztajn et al.

Summary: This study found significant differences in resource use and hospitalization among children with shortness of breath in different European emergency departments, even after adjusting for patient characteristics. Possible explanations for this variability may include unmeasured patient characteristics, differences in guideline use and adherence, or local practice patterns.

PLOS ONE (2021)

Article Immunology

Respiratory syncytial virus and influenza hospitalizations in Danish children 2010-2016

Andreas Jensen et al.

Summary: The study aimed to describe the epidemiology and compare risk factors for hospitalization associated with respiratory syncytial virus (RSV) and influenza virus infections in Danish children. It found that prior asthma hospitalization, number of children in the household, chronic disease, and maternal history of asthma hospitalization were the most important risk factors for both RSV and influenza hospitalization. The findings enable targeted vaccination programs for high-risk children with specific risk factors.

VACCINE (2021)

Article Public, Environmental & Occupational Health

Seasonal shift in epidemics of respiratory syncytial virus infection in Japan

Takeshi Miyama et al.

Summary: This study investigated the changing epidemic seasonality of respiratory syncytial virus (RSV) infection in Japan, finding that the epidemic season has shifted earlier in the year from 2012-2016 to 2017-2019. Although the reason for this shift is unclear, the information may be beneficial for clinical practice and public health.

EPIDEMIOLOGY AND INFECTION (2021)

Article Medicine, General & Internal

Data resource profile: JMDC claims database sourced from health insurance societies

Katsuhiko Nagai et al.

Summary: JMDC, Inc. has developed a unique health insurance database in Japan, with data on claims, health checkup results, and anonymized individual IDs dating back to 2005. Despite its benefits, the database has limitations in determining disease status and lack of data access for the elderly.

JOURNAL OF GENERAL AND FAMILY MEDICINE (2021)

Article Infectious Diseases

Evaluation of using ICD-10 code data for respiratory syncytial virus surveillance

Wei Cai et al.

INFLUENZA AND OTHER RESPIRATORY VIRUSES (2020)

Article Medicine, General & Internal

Respiratory Syncytial Virus Vaccination during Pregnancy and Effects in Infants

S. A. Madhi et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Article Medicine, General & Internal

Single-Dose Nirsevimab for Prevention of RSV in Preterm Infants

M. Pamela Griffin et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Article Public, Environmental & Occupational Health

Detection of the Onset of the Epidemic Period of Respiratory Syncytial Virus Infection in Japan

Hidetomi Yamagami et al.

FRONTIERS IN PUBLIC HEALTH (2019)

Article Infectious Diseases

Respiratory Syncytial Virus Surveillance System in Japan: Assessment of Recent Trends, 2008-2015

Kazuhiko Kanou et al.

JAPANESE JOURNAL OF INFECTIOUS DISEASES (2018)

Article Public, Environmental & Occupational Health

Validation of an algorithm to estimate gestational age in electronic health plan databases

Qian Li et al.

PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2013)

Article Public, Environmental & Occupational Health

Development of a Database of Health Insurance Claims: Standardization of Disease Classifications and Anonymous Record Linkage

Shinya Kimura et al.

JOURNAL OF EPIDEMIOLOGY (2010)

Review Pediatrics

Diagnosis and management of bronchiolitis

Allan S. Lieberthal et al.

PEDIATRICS (2006)